Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Accounts Payables (2016 - 2025)

AC Immune has reported Accounts Payables over the past 11 years, most recently at $2.6 million for Q4 2025.

  • Quarterly Accounts Payables fell 14.72% to $2.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Dec 2025, down 14.72% year-over-year, with the annual reading at $2.6 million for FY2025, 14.72% down from the prior year.
  • Accounts Payables was $2.6 million for Q4 2025 at AC Immune, up from $2.0 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $2.2 billion in Q4 2021 and troughed at $349904.7 in Q2 2022.
  • The 5-year median for Accounts Payables is $2.3 million (2025), against an average of $254.2 million.
  • Year-over-year, Accounts Payables plummeted 99.96% in 2022 and then soared 196185.83% in 2023.
  • A 5-year view of Accounts Payables shows it stood at $2.2 billion in 2021, then plummeted by 99.96% to $964322.4 in 2022, then skyrocketed by 196185.83% to $1.9 billion in 2023, then crashed by 99.84% to $3.0 million in 2024, then decreased by 14.72% to $2.6 million in 2025.
  • Per Business Quant, the three most recent readings for ACIU's Accounts Payables are $2.6 million (Q4 2025), $2.0 million (Q3 2025), and $3.3 million (Q2 2025).